A major hurdle in the development of biomedical nanoparticles (NP) is understanding how they interact with complex biological systems and navigate biological barriers to arrive at pathological targets. It is becoming increasingly evident that merely controlling particle physicochemical properties may not be sufficient to mediate particle biodistribution in dynamic environments. Thus, researchers are increasingly turning toward more complex but likewise more physiological in vitro systems to study particle–-cell/particle–system interactions. An emerging paradigm is to utilize naturally migratory cells to act as so-called “Trojan horses” or cellular shuttles. We report here the use of monocytes/macrophages to transport NP across a confluent e...
Epithelial cell membranes as the typical biological barrier constitute the prime obstacle for the tr...
The nature of macrophage allows the possibility that this cell type could be used as drug delivery s...
The nature of macrophage allows the possibility that this cell type could be used as drug delivery s...
A major hurdle in the development of biomedical nanoparticles (NP) is understanding how they interac...
A major hurdle in the development of biomedical nanoparticles (NP) is understanding how they interac...
A major hurdle in the development of biomedical nanoparticles (NP) is understanding how they intera...
Elevated monocyte/macrophage-derived microparticles (MPs) have been found to correlate with thrombot...
Various nanoparticles have been investigated as drug carriers for delivery to diseased cells in the ...
A polarized layer of endothelial cells that comprises the blood-brain barrier (BBB) precludes access...
Intracellular delivery of nanocarriers (NC) is controlled by their design and target cell phenotype,...
The blood brain barrier (BBB) represents a challenge in the development of new nano-delivery systems...
Bio-mimicking microfluidic devices have been developed to provide a biologically relevant framework ...
A polarized layer of endothelial cells that comprises the blood–brain barrier (BBB) precludes access...
<div><p>The nature of macrophage allows the possibility that this cell type could be used as drug de...
Nanoparticles are small objects in the scale of nanometres (a billionth of a metre), used for a wide...
Epithelial cell membranes as the typical biological barrier constitute the prime obstacle for the tr...
The nature of macrophage allows the possibility that this cell type could be used as drug delivery s...
The nature of macrophage allows the possibility that this cell type could be used as drug delivery s...
A major hurdle in the development of biomedical nanoparticles (NP) is understanding how they interac...
A major hurdle in the development of biomedical nanoparticles (NP) is understanding how they interac...
A major hurdle in the development of biomedical nanoparticles (NP) is understanding how they intera...
Elevated monocyte/macrophage-derived microparticles (MPs) have been found to correlate with thrombot...
Various nanoparticles have been investigated as drug carriers for delivery to diseased cells in the ...
A polarized layer of endothelial cells that comprises the blood-brain barrier (BBB) precludes access...
Intracellular delivery of nanocarriers (NC) is controlled by their design and target cell phenotype,...
The blood brain barrier (BBB) represents a challenge in the development of new nano-delivery systems...
Bio-mimicking microfluidic devices have been developed to provide a biologically relevant framework ...
A polarized layer of endothelial cells that comprises the blood–brain barrier (BBB) precludes access...
<div><p>The nature of macrophage allows the possibility that this cell type could be used as drug de...
Nanoparticles are small objects in the scale of nanometres (a billionth of a metre), used for a wide...
Epithelial cell membranes as the typical biological barrier constitute the prime obstacle for the tr...
The nature of macrophage allows the possibility that this cell type could be used as drug delivery s...
The nature of macrophage allows the possibility that this cell type could be used as drug delivery s...